OrisDX’s Post

🌟 Why & How Series: Empowering Better Outcomes at WVU Camden Clark with LungVision🌟 This week, we’re shining the spotlight on WVU Medicine Camden Clark Medical Center and their experience with LungVision®. ❓Why did WVU Camden Clark choose LungVision?❓  As a forward-thinking healthcare provider, Dr. Roshen Mathew MD DAABIP recognized early on the value of incorporating real-time imaging to enhance diagnostic accuracy, streamline workflows, and ultimately provide better care for their patients. ❓How has this advanced system transformed their practice❓  Since implementing LungVision®, WVU Camden Clark has... 1️⃣ Improved Clinical Outcomes: Dr. Mathew and his team has boosted their diagnostic yield from 68% to 88% since acquisition of LungVision®. 2️⃣ Grown the Program: With real-time imaging providing the visualization Dr. Mathew needed to go after pulmonary nodules he previously might not have attempted, Dr. Mathew has grown procedural volume by 243%. 3️⃣ Flexibility to Grow: LungVision® is brand agnostic, works with their existing bronchoscopy setup, and yet can adapt to whatever technologies the pulmonology team may choose to adopt in the future. 4️⃣ Created a Profitable Program: Even with the added cost of the optional LungVision® procedural kits, the pulmonology team at WVU Camden Clark demonstrated a $3,000 contribution margin per lung nodule biopsy case, at least $1,000 more per case than if they had adopted robotics. The clinical and financial benefits of LungVision® speak for themselves, as the system's ability to cost-effectively boost clinical outcomes and optimize the navigational bronchoscopy workflow has contributed to the growth and sustainability of the lung nodule program at WVU Camden Clark. Want to learn more about how WVU Camden Clark implementation of LungVision® has benefited their lung nodule program?  Check out their full success story here:   👉 https://lnkd.in/gFNmdbw3 #AIinHealthcare #NavigationalBronchoscopy #LungVision #BodyVisionMedical #HealthcareInnovation #LungCancer #RealTimeImaging #AIpowered #AdvancedBronchoscopy

🌟 4 Reasons Why with LungVision®, It's Not, "Can I Afford It?" but, "Can I Afford Not To?" 🌟 In today's healthcare environment, making the right investment in technology can be a game-changer for both clinicians and patients. LungVision® by Body Vision Medical is a prime example of such transformative technology. Here are four compelling reasons why LungVision® AI-driven image guidance is a critical investment you can't afford to overlook: Superior Clinical Outcomes 🩺 LungVision's real-time imaging and advanced navigation capabilities dramatically improves clinicians' ability to definitely diagnose (or rule out) lung cancer, reducing diagnosis to treatment times, improving survival rates, and elevating quality of life for patients. Radiation Reduction 🌟 LungVision® reduces the need for excessive radiation during procedures, protecting both patients and healthcare providers. Flexibility 🔄 Whether you're working with reusable bronchoscopes or robotic bronchoscopy platforms, LungVision® integrates seamlessly with existing workflows and equipment, allowing for a more precise, streamlined (read shorter) lung nodule biopsy procedure. Cost Savings 💰 Beyond a lower upfront investment, LungVision® delivers significant cost savings over time by lowering or eliminating cost-per-case as well as improving diagnostic accuracy and reducing complications. Investing in LungVision® by Body Vision Medical means prioritizing excellence in patient care, operational efficiency, and long-term financial health. It's not just about affording the technology—it's about recognizing the invaluable benefits it brings to your practice and your patients. 🔗 Learn how institutions like Cleveland Clinic, North Memorial Health Hospital, and Jefferson Einstein Montgomery Hospital revolutionized their lung nodule programs with LungVision®: https://lnkd.in/dV7dDtx #HealthcareInnovation #LungVision #BodyVisionMedical #ClinicalOutcomes #RadiationReduction #MedicalTechnology #CostSavings #HealthcareExcellence #AdvancedBronchoscopy #LungCancer

Thank you, Modern Retina, for interviewing our Medical Advisor, Durga S. Borkar, MD, MMCi, about our #RWD research, in collaboration with Genentech and Bausch + Lomb, that was presented during #RetinaWorldCongress. Dr. Borkar also shared how our Qdata Geographic Atrophy module is unlocking new research possibilities by linking EHR + imaging data for a complete view of a patient's healthcare journey. https://hubs.la/Q02yBRR-0

Reversing the ratio of negative biopsies could save US healthcare up to $3 billion annually and reduce burdens on your radiologists. To see how Imagio® can eliminate overutilization, improve the care pathway, and help imaging centers expand their offerings, explore the full story at https://lnkd.in/gkDc_NHK “The cost [of unnecessary diagnostic procedures] is staggering, and we are frankly running up against a limitation of our capacity.” – Michael Bruno, MD, Vice Chair for Quality and Patient Safety, Penn State Milton S. Hershey Medical Center #BreastCancer #optoacoustic #ImagioImaging Reference: Vlahiotis, A., Griffin, B., Stavros, A. T., & Margolis, J. (2018). Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography. ClinicoEconomics and outcomes research: CEOR, 10, 157–167. https://lnkd.in/gFbfjyyA

🎉 Only 2 Days Left Until SBI 2024! 🎉 The countdown is on! Don’t miss out on meeting AbbaDox at Booth 324, where we're changing the game for mammography workflows. Join us in Montreal, April 10-13, for a firsthand look at how we make things easier and better in breast health care. We’re Bringing to the Table: -Audit-Ready: Generate accurate and timely MQSA reports with ease. Streamlined Management: Effortlessly oversee appointments, records, and reports. -Activity Tracking: Coordinate and monitor your outreach initiatives for recall and follow-up appointments. -Biopsy & Pathology: Capture and structure vital biopsy and pathology data swiftly. -Lay Letters: Easily view and print patient lay letters, streamlining communication. With AbbaDox, step into a world where mammography workflows are not just efficient but also patient-centric. 👉 Meet us in 2 days at SBI 2024 and see how our solutions can transform your practice! https://hubs.la/Q02sbyHg0

Our recent webinar with Dr. Jacob Lang was a great success! We delved into neurotrophic keratitis (NK), corneal sensitivity, patient identification, categorization, and treatment modalities. Don't miss out on these valuable insights. Watch the full session at woou.org #Webinar #NeurotrophicKeratitis #Optometry #MedicalEducation #WooUniversity

🚀 Advancing Diagnostics in Norway! 🚀 Sectra expands its partnership with Helse Nord RHF to include digital pathology, transforming case reviews and collaboration for pathologists. This innovative solution streamlines workflows, reduces manual tasks, and enhances patient care—particularly for cancer diagnoses. With faster, remote access to tissue images and a scalable, vendor-neutral platform, Sectra's technology ensures better collaboration across hospitals and specialties. Together, they're setting new standards in diagnostic efficiency. https://lnkd.in/e9C3e5dH 📰 Stay ahead in healthcare by following Practical Patient Care on LinkedIn! Get the latest news and insights on patient care and clinical advancements. Join our community to stay informed and enhance your knowledge. Follow us today! #practicalPatientCare #DigitalPathology #HealthcareInnovation #PatientCare

🍈GE HealthCare announces new Pristina Via system to streamline mammography workflows Pristina Via is designed to improve the screening experience for both technologists and patients. The system, to be debuted at the Radiological Society of North America’s 2024 Annual Meeting, offers advanced tools for technologists. These tools enhance diagnostic accuracy and support fast workflows to deliver more patient-centred breast care. GE HealthCare said that, despite the global shortage of technologists, the demand for mammograms from women remains steady. The company also highlighted the growing need for more efficient and intelligent workflows. Read more online: https://lnkd.in/gPPf2Q6y 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

Serac Healthcare, with the University of Oxford, has advanced early-stage endometriosis diagnosis using 99mTc-maraciclatide. This non-invasive imaging agent, revealed at the European Endometriosis Congress, matches surgical findings, potentially cutting the nine-year diagnosis delay. Insight - ▶ This could revolutionize how we detect and treat endometriosis, impacting millions of women. Questions - ▶ How will this change diagnostic practices? ▶ What are the next steps for commercial use? #Endometriosis #HealthcareInnovation #MedicalBreakthroughs #EarlyDetection

Listen to Dr. Jay P. Patel, a Breast Imaging Radiologist at Quantum Radiology, as he discusses the Find It Early Act, the new FDA requirements for informing women about dense breast tissue, and how to support efforts aimed at enhancing and safeguarding access to breast healthcare. https://lnkd.in/eKpNtPV5 Take Action: Tell Congress to PASS the Find It Early Act to ensure access to life-saving breast health services for women across the country! https://ow.ly/9JBa50TCeNb